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Symmetrical Drug-Related Intertriginous and Flexural Exanthema Induced by
Cellulitis Prophylaxis
Abstract
Penicillin VK and hydroxyzine are typically well-tolerated antipruritic agents that are indicated in the
prophylaxis of cellulitis. We herein report a case of a unique rash occurring during penicillin VK and
hydroxyzine treatment in combination with the ingestion of cashews.
A 77-year-old male presented with new onset rash. Eleven days after the administration of penicillin VK
and hydroxyzine for cellulitis prophylaxis, he developed a symmetric, erythematous, scaling rash on his
buttocks and perineal region with associated pruritus and bleeding without fevers, chills, adenopathy,
night sweats, or any other symptoms. He was diagnosed with symmetrical drug-related intertriginous and
flexural exanthema (SDRIFE) secondary to systemic treatment, an adverse drug reaction that presents as
an erythematous rash involving the skin folds. The condition is also known as “baboon syndrome,” as it
predominately affects the buttocks. A good outcome was achieved due to a thorough history and
physical, timely diagnosis, and cessation of the offending agents.
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Abstract
Penicillin VK and hydroxyzine are typically
well-tolerated antipruritic agents that are
indicated in the prophylaxis of cellulitis. We
herein report a case of a unique rash occurring
during penicillin VK and hydroxyzine
treatment in combination with the ingestion of
cashews.
A 77-year-old male presented with new onset
rash. Eleven days after the administration of
penicillin VK and hydroxyzine for cellulitis
prophylaxis, he developed a symmetric,
erythematous, scaling rash on his buttocks and
perineal region with associated pruritus and
bleeding without fevers, chills, adenopathy,
night sweats, or any other symptoms. He
was diagnosed with symmetrical drugrelated intertriginous and flexural exanthema
(SDRIFE) secondary to systemic treatment,
an adverse drug reaction that presents as an
erythematous rash involving the skin folds.
The condition is also known as “baboon
syndrome,” as it predominately affects the
buttocks. A good outcome was achieved due
to a thorough history and physical, timely
diagnosis, and cessation of the offending
agents.

Introduction

chills, adenopathy, night sweats, or any other
symptoms. The patient tried multiple over
the counter medications for the rash without
relief, including topical antifungal cream. He
did not have any recent travel, changes to
soap or laundry detergent, or any other new
exposures.
Further medical history included chronic
kidney disease, heart failure with preserved
ejection fraction (treated with sotalol,
terazosin, irbesartan, and furosemide),
hypertension (treated with amlodipine),
and long-standing overall body xerosis.
Skin examination demonstrated diffuse
lichenified plaques with marked fissures,
scaling, and crusting on the buttocks (Fig. 1
A and B). Chronologically, penicillin VK and
hydroxyzine, were the only imputable drugs,
as all others had been taken for several years
(Sotalol, terazosin, irbesartan, furosemide, and
amlodipine). In this case, penicillin VK and
hydroxyzine were immediately discontinued.
The patient was switched to triamcinolone
0.1% ointment BID and clobetasol 0.05%
ointment BID to the affected area with

A

petrolatum for xerosis and demonstrated
marked improvement at two-week follow-up.

Discussion
Adverse reactions to medications often
present with involvement of the integument.
They are characterized by the rapid change of
skin appearance (erythema and dryness) and
associated symptoms (pruritis) culminating
in a visible rash. The challenge for physicians
is to determine the etiology of such rashes to
effectively treat them. Often, cessation of the
offending agent resolves the rash.
Symmetrical drug-related intertriginous and
flexural exanthema (SDRIFE) is caused by
a sensitization to a topical agent followed
by systemic exposure to therapeutic agents.
SDRIFE is rare, with only about 100 cases
reported since it was first described in 1984.3
The rash can affect all age groups but is
rare in children. SDRIFE exhibits a male
predominance of 3:1.4

B

Adverse reactions to medications often
present with involvement of the integument.
They are characterized by the rapid change of
skin appearance (erythema and dryness) and
associated symptoms (pruritus) culminating in
a visible rash.1 The challenge for physicians
is to determine the etiology of such rashes to
effectively treat them. Often, cessation of the
offending agent resolves the rash.2

Case
A 77-year-old male with a history of bilateral
lower extremity lymphedema and over 30
episodes of cellulitis since August 2015 was
started on 250 mg oral penicillin VK twice
daily for cellulitis prophylaxis in August
2020. Additionally, he was placed on 10 mg
oral hydroxyzine four times a day for pruritis.
Eleven days after starting these treatments, he
developed a symmetric, erythematous, scaling
rash on his buttocks and perineal region
with associated pruritus and bleeding (Fig.
1 A and B). He did not describe any fevers,
24 Case Reports

Figure 1. Photographs (A and B) of buttock region showing lichenified plaques with marked fissures,
scaling and crusting. (Photos obtained and shared with patient consent.) Dermatology was consulted,
and the patient’s symptoms were attributed to symmetrical drug-related intertriginous and flexural
exanthem (SDRIFE), a systemic drug-related contact dermatitis characterized by symmetric welldemarcated patches of erythema on the buttocks and intertriginous areas. This condition is also
known as Baboon Syndrome due to its characteristic morphology similar to the markings of a baboon.
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The pathogenesis of SDRIFE is unclear, but
there are two widely accepted theories. One
is that SDRIFE develops as a result of a type
IV delayed hypersensitivity immune response.
This is supported by immunohistochemical
evidence for CD4+ T cell infiltration and
increased recruitment of type 1 helper T cells
to sites of inflammation.3 This involves both
a type IVa hypersensitivity reaction with
CD4+ Th1 cells and macrophages, as well
as a type IVc hypersensitivity reaction with
cytotoxic CD4 and CD8 T cells.3 However,
this theory does not explain the occurrence of
SDRIFE after first exposure to a drug without
prior sensitization. The second SDRIFE
pathogenesis theory describes a reactivation of
tissue toxicity at the intertriginous predilection
sites. This involves direct interactions of the
offending drug with immunoreceptors at the
large folds due to the abundance of eccrine
sweat glands, termed “recall phenomenon.”6
SDRIFE can be caused by agents such as
penicillin, hydroxyzine, and cashews, all of
which the patient was exposed to prior to
development of symptoms.7,8 Many other
agents can cause SDRIFE. The most common
culprits are beta-lactam antibiotics, while
other anti-infectious agents and topical agents
such as metronidazole and nystatin, have also
been reported.9 The diagnosis relies mostly
on clinical presentation and history, and the
exclusion of other causes for a rash, such as
environmental exposures, immunosuppressive
manifestations, or infectious etiologies.
Laboratory investigations are performed
to exclude systemic involvement (such as
cytopenia, hepatic or renal involvement),
which are absent in SDRIFE. Patch tests,
lymphocyte transformation tests, and drug
provocation tests can be useful for diagnosis,
but the outcomes of these tests are highly
variable and are not routinely needed. Skin
patch tests are usually the preferred means
of testing, as they are applied directly to
previously affected areas, and they produce
a positive reaction in up to 50% of patients.10
This low rate of positivity may be because
the systemic agent is not completely absorbed
when applied to the skin during patch testing.
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Controlled drug-provocation testing is
considered as the gold standard clinical test
and gives a positive result in most patients
with SDRIFE. Positive drug provocation
testing has been reported for cases of SDRIFE
with clindamycin, cimetidine, corticosteroids,
terbinafine, and valacyclovir.3 General
treatment for SDRIFE is discontinuation of
the offending agent. Supportive therapy such
as topical steroid treatments to target pruritus
may be used. The disease course is typically
self-limiting, and since this is not an allergic
reaction, the causative medication may
cautiously be re-introduced in the future.

Conclusions
Erythema and pruritus following initiation
of a new medication may indicate an adverse
drug reaction, even in patients without a
history of previous reactions. In this case,
correlation of the rash with the administration
of penicillin and hydroxyzine, as well as
cashew ingestion prompted cessation of the
offending agents and rapid improvement.
This case underscores the value of a thorough
history and physical in combination with a
broad differential in the diagnosis of pruritic
rash and highlights the value in understanding
polypharmacy and medical reconciliation. 
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